GW26-e2330 Efficacy and safety of 1-hour infusion of recombinant human atrial natriuretic peptide in patients with acute decompensated heart failure: a phase III, randomized, double-blind, placebo-controlled, multicenter trial

Autor:	Pengbo Wang, Li-Yian Yu, Jun-Zhu Chen, Shu-Gong Bai, Ping Yang, Wei Li, Ji-Hong Zhu, Jian-Hui Sun, Shao-Dong Ye, Yang Wang, Wenxian Liu, Yang Zhen, Lang Hong, Yi-Shi Li, Lei Feng, Xiao-Jun Luan, Guo-Gan Wang, Dong-Ye Li, Xian Wang, Si-Jia Wang
Rok vydání:	2015
Předmět:	medicine.medical_specialty Acute decompensated heart failure business.industry Placebo medicine.disease law.invention Double blind Atrial natriuretic peptide law Internal medicine Multicenter trial medicine Recombinant DNA Cardiology In patient Cardiology and Cardiovascular Medicine business
Zdroj:	Journal of the American College of Cardiology. 66:C208
ISSN:	0735-1097
DOI:	10.1016/j.jacc.2015.06.796
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0beaea6b089ef36ed048ebf6eee0d2c9 https://doi.org/10.1016/j.jacc.2015.06.796 Zobrazit plný text záznamu